Gara Jalqabaatti › Dukkana Bile Duct (Cholangiocarcinoma) › New York › New York City
Qorannoo klinikaalii Dukkana Bile Duct (Cholangiocarcinoma) New York City, NY keessatti
Qorannoo 11 Dukkana Bile Duct (Cholangiocarcinoma) f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study of PHST001 in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Mount Sinai, New York
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Memorial Sloan Kettering Cancer Center (Site 108), New York
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Memorial Sloan Kettering Cancer Centers, New York
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- New York University Langone Health, New York
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Cancer Center, New York
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Namoota walitti qabaa jiraSadarkaa 4
- New York Presbyterian Hospital-Columbia University Medical Center, New York
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Namoota walitti qabaa jiraSadarkaa 2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of MGC028 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Icahn School of Medicine at Mt. Sinai, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, New York
The Dragon PLC Trial (DRAGON-PLC)
Namoota walitti qabaa jira
- Memorial Sloan Kettering Cancer Center, New York
Qorannoo Dukkana Bile Duct (Cholangiocarcinoma) magaalota biroo keessatti
- Houston, TXQorannoo 13
- Boston, MAQorannoo 8
- Rochester, MNQorannoo 7
- Arlington, VAQorannoo 7
- Los Angeles, CAQorannoo 7
- Chicago, ILQorannoo 7
- Columbus, OHQorannoo 6
- Cleveland, OHQorannoo 6
- Edison, NJQorannoo 5
- Queens, NYQorannoo 5
- Grand Rapids, MIQorannoo 5
- Nashville, TNQorannoo 5
Qorannoo biroo New York City keessatti
- Saree OljooQorannoo 136
- Kansara Qara'a Non-Small CellQorannoo 121
- Saree (Gosoota Hunda)Qorannoo 109
- Kansarii ProstateQorannoo 103
- Kansara MetastatikiiQorannoo 93
- Kansarii ColorectalQorannoo 78
- Kansarii OvariiQorannoo 69
- Dhibee QaraQorannoo 60
- Myeloma Baay’eeQorannoo 60
- Kansarii PancreasQorannoo 60
- Kansa EndometiriyaaliiQorannoo 52
- Leukemia Myeloidii HamaaQorannoo 51
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.